Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 37,861 shares of the business's stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total transaction of $810,982.62. Following the completion of the sale, the director now owns 1,184,589 shares of the company's stock, valued at $25,373,896.38. The trade was a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Jennifer Straumins also recently made the following trade(s):
- On Tuesday, November 12th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The stock was sold at an average price of $20.59, for a total value of $2,059,000.00.
Calumet Specialty Products Partners Price Performance
Shares of CLMT traded up $0.09 on Friday, reaching $20.39. 2,068,709 shares of the stock traded hands, compared to its average volume of 424,788. The stock's 50-day moving average price is $21.32 and its 200-day moving average price is $18.09. The firm has a market cap of $1.75 billion, a price-to-earnings ratio of -7.39 and a beta of 1.91. Calumet Specialty Products Partners, L.P. has a 12 month low of $9.97 and a 12 month high of $25.29.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The oil and gas company reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by ($0.59). The business had revenue of $1.10 billion for the quarter, compared to analysts' expectations of $888.36 million. Calumet Specialty Products Partners's revenue for the quarter was down 4.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.03 earnings per share. As a group, equities research analysts forecast that Calumet Specialty Products Partners, L.P. will post -2.87 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Raymond James & Associates grew its stake in shares of Calumet Specialty Products Partners by 13.4% in the 2nd quarter. Raymond James & Associates now owns 572,057 shares of the oil and gas company's stock valued at $9,182,000 after purchasing an additional 67,689 shares during the period. Wasserstein Debt Opportunities Management L.P. boosted its stake in Calumet Specialty Products Partners by 2.9% in the 2nd quarter. Wasserstein Debt Opportunities Management L.P. now owns 6,891,314 shares of the oil and gas company's stock valued at $110,606,000 after buying an additional 193,063 shares in the last quarter. Creative Planning grew its position in Calumet Specialty Products Partners by 46.4% in the second quarter. Creative Planning now owns 62,459 shares of the oil and gas company's stock valued at $1,002,000 after acquiring an additional 19,800 shares during the period. Founders Financial Alliance LLC raised its stake in Calumet Specialty Products Partners by 8.4% during the second quarter. Founders Financial Alliance LLC now owns 48,400 shares of the oil and gas company's stock worth $777,000 after acquiring an additional 3,750 shares in the last quarter. Finally, DRW Securities LLC bought a new position in shares of Calumet Specialty Products Partners during the second quarter valued at $898,000. Institutional investors and hedge funds own 34.41% of the company's stock.
Analyst Ratings Changes
A number of research firms have issued reports on CLMT. HC Wainwright reaffirmed a "buy" rating and issued a $25.00 target price on shares of Calumet Specialty Products Partners in a report on Monday, November 11th. TD Cowen lowered their price objective on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. StockNews.com upgraded shares of Calumet Specialty Products Partners to a "sell" rating in a research note on Monday, November 18th. Finally, Wells Fargo & Company raised their price target on shares of Calumet Specialty Products Partners from $25.00 to $29.00 and gave the stock an "overweight" rating in a research report on Monday, October 21st. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $23.75.
Read Our Latest Report on CLMT
About Calumet Specialty Products Partners
(
Get Free Report)
Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.
See Also
Before you consider Calumet Specialty Products Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.
While Calumet Specialty Products Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
